Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TV005 in Elderly (50-70 Years) in Taiwan
NCT04133987Phase 2Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Oct 2018
- Primary completion
- Apr 2020
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of TetraVax-DV in dengue fever, sponsored by National Taiwan University Hospital. Started Oct 2018; status: completed.
02
Drugs
TetraVax-DV
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT04133987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04133987.